Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer

2003 ◽  
Vol 107 (6) ◽  
pp. 1030-1037 ◽  
Author(s):  
Satoru Shintani ◽  
Chunnan Li ◽  
Mariko Mihara ◽  
Nagaaki Terakado ◽  
Junya Yano ◽  
...  
Keyword(s):  
Dna Damage ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Oral Cancer ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Combined Treatment ◽  
Growth Factor Receptor ◽  
Damage Repair ◽  
Epidermal Growth

scholarly journals Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance

Oncotarget ◽  
2018 ◽  
Vol 9 (20) ◽  
pp. 15418-15434 ◽  
Author(s):  
Carina Heydt ◽  
Sebastian Michels ◽  
Kenneth S. Thress ◽  
Sven Bergner ◽  
Jürgen Wolf ◽  
...  
Keyword(s):  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Tyrosine Kinase Inhibitor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Growth Factor Receptor ◽  
Epidermal Growth ◽  
Novel Approaches ◽  
Inhibitor Resistance
Sign in / Sign up

Export Citation Format

Share Document